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Background 
 
The pathogenesis of chronic chagasic cardiomyopathy (CCM) is controversial, there aren’t definitive proofs of which are the 
necessary factors to reach the determinate stage. Each host genetic factors could actively participate in the evolution of 
Chagas disease. Whereas the variability of phenotypic expression of the CCM could be because of genetic components of the 
patient, we decided to do a descriptive study of genotype frequencies (GF) of SOD-Mn Ala-9-Val, the enzyme activities of 
superoxide dismutase (SOD), glutathione peroxidase (GPx) and catalase (CAT), and as marker of inflammation factor tumor 
necrosis (TNFalpha) in chagasic patients with cardiomyopathy (G1) and without cardiomyopathy (G2) compared with healthy 
controls (CN).  
Table I. The study of SOD-Mn GF of chagasic patients and CN showed 
significant differences (p <0.01) between them. The activities of CAT, SOD, GPx 
and TNFalpha showed significant differences (p <0.01) between chagasic 
patients and CN.  
Conclusions 
 
The data suggest that polymorphisms and inflamation involved in oxidative stress may have implications in the 
pathogenesis of CCM, modifying individual risk in the development of cardiomyopathies. These biomarkers are potentially 
useful in the design of predictive models to identify chagasic patients at risk of developing clinical complications.  
 
         
         
Methods 
 
The molecular characterization was performed by PCR-RFLP. Enzyme activities were determined by spectrophotometric 
techniques and the tumor necrosis factor alpha (TNFalpha) by immuno method (ELISA - BD OptEIA TNF HU). The hypothesis 
test under normal theory proportions and Kruskal Wallis test were carried out.  
         
G1 G2 CN 
SOD-Mn FG  
(IC 95%)  
Ala/Ala  0.35  
(0.14-0.56) 
0.36  
(0.07-0.64) 
0.54  
(0.40-0.67) 
Ala/Val  0.30 
(0.10-0.50) 
0.46  
(0.16-0.75) 
0.33  
(0.20-0.45) 
Val/Val  0.35  
(0.14-0.56) 
0.18  
(0.00-0.40) 
0.13  
(0.04-0.21) 
CAT(K/gHb) 316±68 332±41 185±28 
GPx(U/gHb) 98±17 102±20 61±11 
SOD(USOD/gHb) 3270±833 2590±188 895±314 
TNFalpha(pg/ml)  33.3±7.2 26.1±6.8 7.7±2.4 
Results 
Graph II. CAT,GPX and SOD 
enzymatic activity and TNFalpha 
in G1, G2 and CN. 
Graph I. SOD-Mn Ala9Val FG. 
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